83C - Executive Order 14168 Compliance

83C_0167_Executive Order 14168_Form FDA 4035.docx

Orphan Drugs

83C - Executive Order 14168 Compliance

OMB: 0910-0167

Document [docx]
Download: docx | pdf

FOOD AND DRUG ADMINISTRATION

Non-substantive Change Request

OMB Control Nos. 0910-0167

Orphan Drugs


Date Submitted: April 15, 2025



Summary of request: The Food and Drug Administration is requesting a change request to revise questions to align with Executive Order (EO) 14168 Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government.


Description of Changes Requested: Remove the prefix “Mx.” from the fields “Primary Contact Prefix” and “Sponsor U.S. Resident Agent Prefix” to be in accordance with EO 14168.


x Revision of an existing question(s)

Deletion of an existing question(s)

Description of Changes to Burden (if applicable):


N/A: No change in burden


Attachments:



Document

Tracked Changes Version

Clean Version

Form FDA 4035






File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created2025-05-20

© 2025 OMB.report | Privacy Policy